GroEL/ES mediated the in vivo recovery of TRAIL inclusion bodies in Escherichia coli

Abstract Inclusion body (IB) formation generates substantial bio-waste in the pharmaceutical industry and remains a major challenge for heterologous protein expression. Although chaperones can be co-expressed to improve soluble protein yield, their contribution to IB processing in vivo has not been...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Zhanqing Wang, Min Zhang, Xin Lv, Jiying Fan, Jian Zhang, Jing Sun, Yaling Shen
Format: article
Langue:EN
Publié: Nature Portfolio 2018
Sujets:
R
Q
Accès en ligne:https://doaj.org/article/9c001b387a9d4afc83e57e681db6a0bc
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
id oai:doaj.org-article:9c001b387a9d4afc83e57e681db6a0bc
record_format dspace
spelling oai:doaj.org-article:9c001b387a9d4afc83e57e681db6a0bc2021-12-02T15:08:49ZGroEL/ES mediated the in vivo recovery of TRAIL inclusion bodies in Escherichia coli10.1038/s41598-018-34090-72045-2322https://doaj.org/article/9c001b387a9d4afc83e57e681db6a0bc2018-10-01T00:00:00Zhttps://doi.org/10.1038/s41598-018-34090-7https://doaj.org/toc/2045-2322Abstract Inclusion body (IB) formation generates substantial bio-waste in the pharmaceutical industry and remains a major challenge for heterologous protein expression. Although chaperones can be co-expressed to improve soluble protein yield, their contribution to IB processing in vivo has not been thoroughly studied. Here, a GroEL-GroES co-expressing strain and a deficient strain were constructed to study the in vivo recovery of recombinant human tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). The interaction between GroEL/ES and TRAIL was simulated by molecular docking and identified by co-immunoprecipitation. The in vitro cytotoxicity of TRAIL IBs before and after in vivo recovery was subsequently determined by MTT assay. Additionally, IB structures were measured by Fourier transform infrared (FT-IR) spectroscopy and fluorescence spectroscopy. The results showed that after in vivo refolding, IBs retained lower levels of anti-tumor activity and fewer native-like β-sheet structures. Fewer recoverable polypeptides were trapped in IBs after GroEL/ES co-expression and refolding in vivo. Therefore, GroEL/ES mediated the in vivo recovery of TRAIL IBs in Escherichia coli. These results may identify potential uses for IBs and provide additional insight into the detailed mechanisms of in vivo protein recovery.Zhanqing WangMin ZhangXin LvJiying FanJian ZhangJing SunYaling ShenNature PortfolioarticleTumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)Soluble TRAILrhTRAILGroE ChaperoninColi Strain C600MedicineRScienceQENScientific Reports, Vol 8, Iss 1, Pp 1-10 (2018)
institution DOAJ
collection DOAJ
language EN
topic Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)
Soluble TRAIL
rhTRAIL
GroE Chaperonin
Coli Strain C600
Medicine
R
Science
Q
spellingShingle Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)
Soluble TRAIL
rhTRAIL
GroE Chaperonin
Coli Strain C600
Medicine
R
Science
Q
Zhanqing Wang
Min Zhang
Xin Lv
Jiying Fan
Jian Zhang
Jing Sun
Yaling Shen
GroEL/ES mediated the in vivo recovery of TRAIL inclusion bodies in Escherichia coli
description Abstract Inclusion body (IB) formation generates substantial bio-waste in the pharmaceutical industry and remains a major challenge for heterologous protein expression. Although chaperones can be co-expressed to improve soluble protein yield, their contribution to IB processing in vivo has not been thoroughly studied. Here, a GroEL-GroES co-expressing strain and a deficient strain were constructed to study the in vivo recovery of recombinant human tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). The interaction between GroEL/ES and TRAIL was simulated by molecular docking and identified by co-immunoprecipitation. The in vitro cytotoxicity of TRAIL IBs before and after in vivo recovery was subsequently determined by MTT assay. Additionally, IB structures were measured by Fourier transform infrared (FT-IR) spectroscopy and fluorescence spectroscopy. The results showed that after in vivo refolding, IBs retained lower levels of anti-tumor activity and fewer native-like β-sheet structures. Fewer recoverable polypeptides were trapped in IBs after GroEL/ES co-expression and refolding in vivo. Therefore, GroEL/ES mediated the in vivo recovery of TRAIL IBs in Escherichia coli. These results may identify potential uses for IBs and provide additional insight into the detailed mechanisms of in vivo protein recovery.
format article
author Zhanqing Wang
Min Zhang
Xin Lv
Jiying Fan
Jian Zhang
Jing Sun
Yaling Shen
author_facet Zhanqing Wang
Min Zhang
Xin Lv
Jiying Fan
Jian Zhang
Jing Sun
Yaling Shen
author_sort Zhanqing Wang
title GroEL/ES mediated the in vivo recovery of TRAIL inclusion bodies in Escherichia coli
title_short GroEL/ES mediated the in vivo recovery of TRAIL inclusion bodies in Escherichia coli
title_full GroEL/ES mediated the in vivo recovery of TRAIL inclusion bodies in Escherichia coli
title_fullStr GroEL/ES mediated the in vivo recovery of TRAIL inclusion bodies in Escherichia coli
title_full_unstemmed GroEL/ES mediated the in vivo recovery of TRAIL inclusion bodies in Escherichia coli
title_sort groel/es mediated the in vivo recovery of trail inclusion bodies in escherichia coli
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/9c001b387a9d4afc83e57e681db6a0bc
work_keys_str_mv AT zhanqingwang groelesmediatedtheinvivorecoveryoftrailinclusionbodiesinescherichiacoli
AT minzhang groelesmediatedtheinvivorecoveryoftrailinclusionbodiesinescherichiacoli
AT xinlv groelesmediatedtheinvivorecoveryoftrailinclusionbodiesinescherichiacoli
AT jiyingfan groelesmediatedtheinvivorecoveryoftrailinclusionbodiesinescherichiacoli
AT jianzhang groelesmediatedtheinvivorecoveryoftrailinclusionbodiesinescherichiacoli
AT jingsun groelesmediatedtheinvivorecoveryoftrailinclusionbodiesinescherichiacoli
AT yalingshen groelesmediatedtheinvivorecoveryoftrailinclusionbodiesinescherichiacoli
_version_ 1718388015886237696